CDEK
← All drugs Report issue

ev71 vaccine

Vaccineexperimental

Clinical trial activity

45 trials · 20 clinical orgs · 0 marketing orgs

Phase 1
9
Phase 2
22
Phase 3
9
Phase 4
17

Earliest trial started Dec 1, 2010 (NCT01268787)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2012

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • enterovirus type 71 (ev71) vaccine
  • ev71 vaccine
  • inactivated enterovirus type 71 (ev71) vaccine
  • inactivated ev71 vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07178522Phase 3Jun 25, 2025Medigen Biotechnology Corporation
NCT06754384Phase 1/Phase 2 (Phase 2)Jan 30, 2025Government of China, Sinovac Biotech Co., Ltd
NCT06734832Phase 3Dec 30, 2024Government of China, Sinovac Biotech Co., Ltd
NCT06146088Phase 4Nov 24, 2023Chinese Academy of Medical Sciences, Government of China
NCT06063057Phase 1/Phase 2 (Phase 2)Sep 20, 2023Government of China, Sinovac Biotech Co., Ltd
NCT05913024Phase 2Oct 19, 2021Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
NCT04467541Phase 1/Phase 2 (Phase 2)Dec 24, 2019International Center for Diarrheal Disease Research
NCT07026500Phase 4Sep 19, 2019Sinovac Biotech Co., Ltd
NCT04091880Phase 4Sep 16, 2019Changchun Institute of Biological Products Co., Ltd., China National Biotec Group Co., Ltd, Government of China, Peking University, Wuhan Institute of Biological Products Co., Ltd
NCT04133584Phase 4Sep 16, 2019China National Biotec Group Co., Ltd, Government of China
NCT04111432Phase 4Jul 26, 2019Government of China, Sinovac Biotech Co., Ltd
NCT03865238Phase 3Apr 1, 2019Medigen Biotechnology Corporation, National Taiwan University
NCT03903926Phase 4Mar 26, 2019Government of China, Sinovac Biotech Co., Ltd
NCT03909074Phase 3Mar 10, 2019Government of China, Sinovac Biotech Co., Ltd
NCT03873740Phase 4Nov 6, 2018Government of China, Sinovac Biotech Co., Ltd
NCT03582761Phase 4Aug 31, 2018Government of China, Wuhan Institute of Biological Products Co., Ltd
NCT05099029Phase 3Jun 27, 2018Enimmune Corporation
NCT06209398Phase 4May 24, 2018Chinese Academy of Medical Sciences, Government of China
NCT03519568Phase 4Mar 1, 2018Government of China
NCT03296410Phase 4Sep 14, 2017Chinese Academy of Medical Sciences, Government of China
Showing 20 of 45 trials
Page 1 / 3

Organizations

Research & Development (20)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment331042010
Sinovac Biotech Co., LtdFor profit161642010
Chinese Academy of Medical SciencesAcademic/Hospital9842011
Bejing Vigoo Biological Co., LTDFor profit6032011
Enimmune CorporationFor profit3322014
Medigen Biotechnology CorporationFor profit3322014
China National Biotec Group Co., LtdFor profit2112019
National Taiwan UniversityAcademic/Hospital2022014
Wuhan Institute of Biological Products Co., LtdGovernment2012018
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.For profit1112021
Capital Medical UniversityAcademic/Hospital1112016
Changchun Institute of Biological Products Co., Ltd.For profit1012019
Chaoyang Provincial Center for Diseases Control and Prevention in BeijingGovernment1012016
Dongguan Municipal Center for Disease Control and PreventionGovernment1012017
Government of TaiwanGovernment1112010
Guangdong Provincial Center for Disease Control and PreventionGovernment1012017
International Center for Diarrheal Disease ResearchAcademic/Hospital1112019
Peking UniversityAcademic/Hospital1012019
Taipei Medical UniversityAcademic/Hospital1012010
Taipei Veteran General hospitalGovernment1012010
20 organizations
Page 1 / 1